RESUMEN
CCL20/MIP-3alpha is a beta-chemokine expressed in the thymus, skin, and intestinal epithelial cells that exclusively binds and activates the CCR6 receptor in both mice and humans. The strict receptor binding specificity of CCL20 is exceptional; other chemokines and their receptors bind promiscuously with multiple partners. Toward determining the structural basis for the selective receptor specificity of CCL20, we have determined its three-dimensional structure by 1H NMR spectroscopy. CCL20 exhibits the same monomeric structure previously described for other chemokines: a three-stranded beta-sheet and an overlying alpha-helix. The CCL20 receptor selectivity could arise from the rigid conformation of the N-terminal DCCL motif as well as the groove between the N-loop and the beta2-beta3 hairpin, which is significantly narrower in CCL20 than in other chemokines. Similar structural features are seen in human beta-defensin 2, a small nonchemokine polypeptide reported to selectively bind and activate CCR6, which stresses their importance for the specific binding of both CCL20 and beta-defensin 2 to CCR6. CCL20's structure will be useful to design tools aimed to modulate its important biological functions.
Asunto(s)
Quimiocinas CC/química , Quimiocinas CC/metabolismo , Células Dendríticas/metabolismo , Linfocitos/metabolismo , Proteínas Inflamatorias de Macrófagos/química , Proteínas Inflamatorias de Macrófagos/metabolismo , Estrés Oxidativo , Receptores de Quimiocina/metabolismo , Secuencias de Aminoácidos , Animales , Quimiocina CCL20 , Factores Quimiotácticos/metabolismo , Dimerización , Humanos , Espectroscopía de Resonancia Magnética , Ratones , Modelos Químicos , Modelos Moleculares , Unión Proteica , Conformación Proteica , Pliegue de Proteína , Estructura Secundaria de Proteína , Receptores CCR6 , beta-Defensinas/químicaRESUMEN
CCR6 expression in dendritic, T, and B cells suggests that this beta-chemokine receptor may regulate the migration and recruitment of antigen-presenting and immunocompetent cells during inflammatory and immunological responses. Here we demonstrate that CCR6-/- mice have underdeveloped Peyer's patches, in which the myeloid CD11b+ CD11c+ dendritic-cell subset is not present in the subepithelial dome. CCR6-/- mice also have increased numbers in T-cell subpopulations within the intestinal mucosa. In 2,4-dinitrofluorobenzene-induced contact hypersensitivity (CHS) studies, CCR6-/- mice developed more severe and more persistent inflammation than wild-type (WT) animals. Conversely, in a delayed-type hypersensitivity (DTH) model induced with allogeneic splenocytes, CCR6-/- mice developed no inflammatory response. The altered responses seen in the CHS and DTH assays suggest the existence of a defect in the activation and/or migration of the CD4(+) T-cell subsets that downregulate or elicit the inflammation response, respectively. These findings underscore the role of CCR6 in cutaneous and intestinal immunity and the utility of CCR6-/- mice as a model to study pathologies in these tissues. This article was published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.
Asunto(s)
Dermatitis por Contacto/genética , Dermatitis por Contacto/inmunología , Hipersensibilidad Tardía/genética , Hipersensibilidad Tardía/inmunología , Leucocitos/inmunología , Receptores de Quimiocina/deficiencia , Animales , Linfocitos T CD4-Positivos/inmunología , Movimiento Celular , Femenino , Homeostasis , Mucosa Intestinal/inmunología , Mucosa Intestinal/patología , Células de Langerhans/inmunología , Leucocitos/patología , Activación de Linfocitos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ganglios Linfáticos Agregados/inmunología , Ganglios Linfáticos Agregados/patología , Receptores CCR6 , Receptores de Quimiocina/genética , Receptores de Quimiocina/fisiologíaRESUMEN
Chemokines are involved in the control of dendritic cell (DC) trafficking, which is critical for the immune response. We have generated DC from human umbilical cord blood CD34+ progenitors cultured with granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha (TNF-alpha), and stem cell factor. Using an anti-CCR6 monoclonal antibody, we observed that these cells showed maximum expression of this beta-chemokine receptor when they were immature, as determined by their relatively low expression of several DC maturation markers such as CD1a, CD11c, CD14, CD40, CD80, and CD83. Immature DC responded strongly to macrophage inflammatory protein-3alpha (MIP-3alpha), the CCR6 ligand, in migration and calcium mobilization assays. CCR6 expression decreased in parallel with the DC maturation induced by prolonged TNF-alphaq treatments. Interleukin-4 was also able to decrease CCR6 protein levels. Our findings suggest that the MIP-3alpha/CCR6 interaction plays an important role in the trafficking of immature DC to chemokine production sites such as injured or inflamed peripheral tissues, where DC undergo maturation on contact with antigens.
Asunto(s)
Células Dendríticas/metabolismo , Regulación hacia Abajo , Interleucina-4/metabolismo , Proteínas Inflamatorias de Macrófagos , Receptores de Quimiocina/biosíntesis , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Anticuerpos Monoclonales/biosíntesis , Línea Celular , Quimiocina CCL20 , Quimiocinas CC/metabolismo , Quimiocinas CC/farmacología , Células Dendríticas/efectos de los fármacos , Humanos , Interleucina-4/farmacología , Ratones , Ratones Endogámicos BALB C , Receptores CCR6 , Receptores de Quimiocina/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Spodoptera/citología , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
The phenotype of mouse thymic B cells and their capacity to induce T cell negative selection in vitro were analyzed. Thymic B cells expressed B cell markers such as IgM, Fc gamma receptor, CD44, heat-stable antigen, LFA-1 and CD40. In addition, they were positive for the activation molecule CD69 and displayed high levels of B7-2. Although thymic B cells expressed CD5 on their surface, no CD5-specific mRNA was detected. Moreover, thymic B cells induced a stronger deletion of TCR-transgenic (TG) thymocytes than splenic B cells, which had low CD69 and B7-2 levels. Interestingly, CD40-activated splenic B cells up-regulated CD69 and B7-2 and acquired a capacity to induce T cell deletion comparable to that of thymic B cells. Moreover, thymic B cells from CD40-deficient mice displayed lower CD69 and B7-2 levels than control thymic B cells, and lower capacity to induce the deletion of TCR TG thymocytes. These results support the hypothesis that CD40-mediated activation of thymic B cells determines a high efficiency of antigen presentation, suggesting that within the thymus B cells may play an important role in the elimination of autoreactive thymocytes.
Asunto(s)
Linfocitos B/inmunología , Linfocitos T/inmunología , Animales , Antígenos Virales/inmunología , Linfocitos B/clasificación , Antígenos CD40/genética , Antígenos CD40/inmunología , Antígenos CD5/genética , Antígenos CD8/genética , Femenino , Inmunofenotipificación , Virus de la Coriomeningitis Linfocítica/inmunología , Glicoproteínas de Membrana/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Bazo/citología , Bazo/inmunología , Timo/citología , Timo/inmunologíaRESUMEN
Thymus-expressed chemokine (TECK) has been reported to chemoattract dendritic cells, thymocytes, and activated macrophages. Here, we show that TECK is a specific agonist for a human orphan receptor called GPR-9-6. We have determined the cDNA sequence of human GPR-9-6 and cloned the corresponding murine cDNA. Human and murine GPR-9-6 expression is very high in the thymus and low in lymph nodes and spleen. RT-PCR analysis of murine GPR-9-6 expression on murine FACS-sorted thymocyte subpopulations showed that this gene is expressed in both immature and mature T cells. Additions of human or murine TECK to HEK 293/human GPR-9-6 and HEK 293/murine GPR-9-6 transfectants provoked intracytoplasmic calcium mobilization. Human TECK also induced the in vitro migration of HEK 293/human GPR-9-6 cells. These results confirm that GPR-9-6 is a specific receptor for TECK. According to the established nomenclature system, we propose to rename GPR-9-6 as CC chemokine receptor 9 (CCR9).
Asunto(s)
Quimiocinas CC/metabolismo , Receptores de Quimiocina/genética , Secuencia de Aminoácidos , Animales , Señalización del Calcio , Quimiotaxis de Leucocito , Clonación Molecular , Humanos , Ligandos , Ratones , Datos de Secuencia Molecular , Unión Proteica , ARN Mensajero/aislamiento & purificación , Receptores CCR , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Timo/citología , Distribución TisularRESUMEN
We have cloned the murine CCR6 receptor and its ligand, the beta-chemokine mMIP-3alpha. Calcium mobilization assays performed with mCCR6 transfectants showed significant responses upon addition of mMIP-3alpha. Murine MIP-3alpha RNA is expressed in thymus, small intestine and colon, whereas mCCR6 RNA is expressed in spleen and lymph nodes. RT-PCR analysis of FACS-sorted lymphoid and antigen presenting cell subsets showed mCCR6 expression mainly in B cells, CD8- splenic dendritic cells and CD4+ T cells. The cloning and functional characterization of the mCCR6 and mMIP-3alpha will allow the study of the role of these proteins in mouse models of inflammation and immunity.
Asunto(s)
Quimiocinas CC/genética , Quimiocinas CC/farmacología , Clonación Molecular , Expresión Génica , Proteínas Inflamatorias de Macrófagos , Receptores de Quimiocina/genética , Secuencia de Aminoácidos , Animales , Células Presentadoras de Antígenos/metabolismo , Señalización del Calcio/efectos de los fármacos , Línea Celular , Quimiocina CCL20 , Quimiocinas CC/síntesis química , Quimiocinas CC/química , Biblioteca de Genes , Humanos , Ligandos , Tejido Linfoide/metabolismo , Ratones , Datos de Secuencia Molecular , Especificidad de Órganos , Señales de Clasificación de Proteína , ARN Mensajero/análisis , ARN Mensajero/genética , Receptores CCR6 , Receptores de Quimiocina/química , Receptores de Quimiocina/metabolismo , Alineación de Secuencia , TransfecciónRESUMEN
Chemokine receptor-like 1 (CKR-L1) was described recently as a putative seven-transmembrane human receptor with many of the structural features of chemokine receptors. To identify the ligand of CKR-L1, we have studied chemokine-induced calcium mobilization in 293 cells transfected with CKR-L1. Of 20 different chemokines tested, only I-309 was able to elicit a significant calcium mobilization. In addition, I-309 induced the transfectants to migrate in vitro. As expected for chemokine receptor-mediated effects, pertussis toxin, but not cholera toxin, inhibited both the calcium flux and migration of the CKR-L1 transfectants in response to I-309. All of these data support the conclusion that I-309 is a functional ligand for CKR-L1. According to the current chemokine receptor nomenclature, we have designated this gene as CCR8. The murine CCR8 (mCCR8) gene was cloned, and its predicted amino acid sequence showed a 71% identity with that of human CCR8. As human CCR8, mCCR8 is expressed in thymus. Both I-309 and its murine homologue TCA-3 were able to induce calcium mobilization in transiently transfected 293-EBNA cells expressing mCCR8. The affinity of the binding of 125I-labeled TCA-3 to mCCR8 was high (Kd approximately 2 nM); the binding was prevented completely by an excess of cold TCA-3, and only partially competed (40%) by I-309. The identification of I-309 and TCA-3 as the functional ligands for CCR8 receptors will help to unravel the role of these proteins in physiologic and pathologic situations.
Asunto(s)
Quimiocinas CC/metabolismo , Citocinas , Receptores de Quimiocina/genética , Receptores de Quimiocina/metabolismo , Receptores de Citocinas/metabolismo , Secuencia de Aminoácidos , Animales , Calcio/metabolismo , Línea Celular , Quimiocina CCL1 , Quimiocinas CC/fisiología , Quimiotaxis/efectos de los fármacos , Clonación Molecular , Humanos , Radioisótopos de Yodo , Riñón/citología , Ratones , Datos de Secuencia Molecular , Receptores CCR8 , Receptores de Quimiocina/biosíntesis , Receptores de Quimiocina/aislamiento & purificación , Homología de Secuencia de Aminoácido , TransfecciónRESUMEN
Two new human genes encoding putative G protein-coupled receptors were cloned from genomic DNA following a degenerate PCR strategy. The predicted amino acid sequences of the proteins encoded by these genes have the characteristic motifs of chemokine receptors. This prompted us to name these genes CKR-L1 and CKR-L3. Nevertheless, the identification of their ligands has not been possible using 16 human chemokines in three different assays. The RNA expression pattern of CKR-L1 and CKR-L3 is also similar to that generally found for chemokine receptors. To a different extent, these genes are expressed in spleen, lymph nodes, and CD4+, CD8+ and CD19+ lymphocytes. CKR-L1 expression was also detected in monocyte/macrophages. The homology to chemokine receptors suggests that CKR-L1 belongs to the family of beta chemokine receptors, while CKR-L3 is more similar to alpha chemokine receptors.
Asunto(s)
ARN/genética , Receptores de Quimiocina , Receptores de Citocinas/genética , Secuencia de Aminoácidos , Mapeo Cromosómico , Clonación Molecular , Humanos , Ligandos , Datos de Secuencia Molecular , Receptores CCR6 , Receptores CCR8 , Receptores de Citocinas/metabolismo , Homología de Secuencia de AminoácidoRESUMEN
Papulacandin B, an antifungal agent that interferes with the synthesis of yeast cell wall (1,3)beta-D-glucan, was used to isolate resistant mutants in Schizosaccharomyces pombe and Saccharomyces cerevisiae. The resistance to papulacandin B always segregated as a recessive character that defines a single complementation group in both yeasts (pbr1+ and PBR1, respectively). Determination of several kinetic parameters of (1,3)beta-D-glucan synthase activity revealed no differences between S. pombe wild-type and pbr1 mutant strains except in the 50% inhibitory concentration for papulacandin B of the synthases (about a 50-fold increase in mutant activity). Inactivation of the synthase activity of both yeasts after in vivo treatment with the antifungal agent showed that mutant synthases were more resistant than the corresponding wild-type ones. Detergent dissociation of the S. pombe synthase into soluble and particulate fractions and subsequent reconstitution indicated that the resistance character of pbr1 mutants resides in the particulate fraction of the enzyme. Cloning and sequencing of PBR1 from S. cerevisiae revealed a gene identical to others recently reported (FKS1, ETG1, CWH53, and CND1). Its disruption leads to reduced levels of both (1,3)beta-D-glucan synthase activity and the alkali-insoluble cell wall fraction. Transformants containing the PBR1 gene reverse the defect in (1,3)beta-D-glucan synthase. It is concluded that Pbr1p is probably part of the (1,3)beta-D-glucan synthase complex.
Asunto(s)
Aminoglicósidos , Antibacterianos/farmacología , Antifúngicos/farmacología , Genes Fúngicos/genética , Glucanos/biosíntesis , Glucosiltransferasas/genética , Proteínas de la Membrana , Péptidos Cíclicos , Proteínas de Schizosaccharomyces pombe , Levaduras/genética , beta-Glucanos , Secuencia de Bases , Sistema Libre de Células , Clonación Molecular , Farmacorresistencia Microbiana/genética , Glucosiltransferasas/antagonistas & inhibidores , Datos de Secuencia Molecular , Mutagénesis , Fenotipo , Mapeo Restrictivo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/fisiología , Schizosaccharomyces/genética , Schizosaccharomyces/fisiología , Análisis de Secuencia de ADN , Homología de Secuencia , Levaduras/fisiologíaRESUMEN
The four temperature-sensitive mutants of Saccharomyces cerevisiae in the cell division cycle defective in cytokinesis (cdc, 3, 10, 11 and 12), have been analyzed with respect to the biosynthesis of the cell wall polymers. After 3 hours of incubation at the non-permissive temperature (37 degrees C) these strains stop growing. The synthesis of glucan, mannan and chitin (wall polymers) level off in a similar time, but glucan, mannan and chitin synthases remained active for at least 4 hours. If the mutants are analyzed by transmission and scanning electron microscopy different pictures emerge. Two of the mutants cdc 10 and cdc 12, after 3 hours of incubation at 37 degrees C present apparently normal cytoplasms and cell wall surfaces with multiple elongated buds. The other two mutants, cdc 3 and cdc 11, present a completely disarranged cytoplasmic content and damage at the level of the plasma membrane is evident. These and other observations, suggest that between the execution points of cdc 3 (0.27) and cdc 10 (0.58), essential processes in the assembly of cell membrane occur.